New Activity

We are proud to present our new activity. Bionobis has recently commercialized a complete system for NGS HLA genotyping. This system includes a fully-automated workflow, kits and a dedicated Analysis Software.

Our knowledgeable R&D team applies their experience to this challenge: How to increase productivity and simplify labs organization.

These are easy questions to ask, but difficult to answer.

With our Nanostar® innovation, we are at the technology forefront – offering an accurate, rapid, and efficient automated-genotyping solution to the labs.

We have high quality products and services while meeting current and future challenges. It has the prospect of formidable growth, creating wealth, services and jobs in France to support this new manufacturing activity over the long term, which is therefore naturally integrated into our “Employer & Systemic Quality” strategy.